IP Group logo

IP Group

Europe, England, United Kingdom, London

Description

IP Group is an IP commercialization company specializing in evolving great ideas into world-changing businesses.

Investor Profile

IP Group has made 288 investments, with 4 in the past 12 months and 20% as lead.

Stage Focus

  • Seed (41%)
  • Series Unknown (22%)
  • Series A (15%)
  • Series B (11%)
  • Series C (5%)
  • Series D (2%)
  • Pre Seed (1%)
  • Undisclosed (1%)
  • Series E (1%)
  • Corporate Round (1%)

Country Focus

  • United Kingdom (81%)
  • United States (11%)
  • Australia (2%)
  • New Zealand (1%)
  • Sweden (1%)

Industry Focus

  • Biotechnology
  • Software
  • Health Care
  • Information Technology
  • Therapeutics
  • Manufacturing
  • Medical
  • Health Diagnostics
  • Analytics
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does IP Group frequently co-invest with?

Oxford Investment Consultants LLP
Europe, Oxfordshire, United Kingdom, Oxford
Co-Investments: 6
Lansdowne Partners
Europe, England, United Kingdom, London
Co-Investments: 9
Woodford Investment Management
Europe, Oxfordshire, United Kingdom, Oxford
Co-Investments: 12
Pfizer Venture Investments
North America, New York, United States, New York
Co-Investments: 6
Octopus Ventures
Europe, England, United Kingdom, London
Co-Investments: 8
Hostplus
Oceania, Victoria, Australia, Melbourne
Co-Investments: 15
Northstar Ventures
Europe, Newcastle upon Tyne, United Kingdom, Newcastle Upon Tyne
Co-Investments: 64
Parkwalk Advisors
Europe, England, United Kingdom, London
Co-Investments: 37
Oxford Science Enterprises
Europe, Oxfordshire, United Kingdom, Oxford
Co-Investments: 15
HC
Europe, England, United Kingdom, London
Co-Investments: 27

Which angels does IP Group often collaborate with?

RS
Europe, Cambridgeshire, United Kingdom, Cambridge
Shared Deals: 1
AT
Europe, Estonia
Shared Deals: 1
Shared Deals: 1
AS
Europe, Surrey, United Kingdom, Guildford
Shared Deals: 1
LL
Europe, Berlin, Germany, Berlin
Shared Deals: 1
AA
Europe, Madrid, Spain, Madrid
Shared Deals: 1
LS
Europe, England, United Kingdom, London
Shared Deals: 1
LM
Europe, Manchester, United Kingdom, Manchester
Shared Deals: 1

What are some of recent deals done by IP Group?

Diffblue

Oxford, Oxfordshire, United Kingdom

Diffblue is a developer of automated testing software that enhances Java development by automatically generating unit tests.

Artificial Intelligence (AI)Developer ToolsGenerative AISoftware
Series AOct 30, 2024
Amount Raised: $6,300,000
Alimetry

Auckland, Auckland, New Zealand

Next Generation Technology for Gastric Disorders

BiotechnologyHealth CareHealth DiagnosticsMedicalMedical Device
Series AOct 28, 2024
Amount Raised: $18,000,000
Alesi Surgical

Cardiff, Cardiff, United Kingdom

Alesi Surgical develops and commercialises products that improve the safety

BiotechnologyHealth CareTherapeutics
Series UnknownSep 19, 2024
Amount Raised: $6,640,653
Microbiotica

Cambridge, Cambridgeshire, United Kingdom

Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers.

BiotechnologyHealth CareTherapeutics
Series UnknownAug 27, 2024
MISSION Therapeutics

Cambridge, Cambridgeshire, United Kingdom

MISSION Therapeutics develops therapies that enhance the removal of dysfunctional mitochondria to combat serious diseases.

BiotechnologyHealth CareLife ScienceTherapeutics
Series DMar 14, 2024
Amount Raised: $32,118,400
Enterprise Therapeutics

Falmer, East Sussex, United Kingdom

A UK-based developer of drugs to treat respiratory diseases

Health CareHealth DiagnosticsTherapeutics
Series BJan 29, 2024
Amount Raised: $33,056,380
Oxford Quantum Circuits

Reading, Reading, United Kingdom

Oxford Quantum Circuits develops quantum computers designed for breakthrough discoveries.

HardwareInformation and Communications Technology (ICT)Information TechnologyQuantum ComputingSoftware
Series BNov 27, 2023
Amount Raised: $100,000,000
Crescendo Biologics

Cambridge, Cambridgeshire, United Kingdom

Crescendo Biologics is engaged in the development of a proprietary drug portfolio based on their VH antibody fragment platform.

BiotechnologyHealth CareTherapeutics
Series UnknownJul 24, 2023
Amount Raised: $32,000,000
OXCCU

Oxford, Oxfordshire, United Kingdom

OXCCU develops renewable energy technology with the goal of achieving a circular economy for fuels, chemicals, and plastics.

BiotechnologyChemicalChemical Engineering
Series AJun 7, 2023
Amount Raised: $22,700,000
AccelerComm

Southampton, Southampton, United Kingdom

AccelerComm is a semiconductor IP-core company specialising in channel coding solutions.

Semiconductor
Series BApr 11, 2023
Amount Raised: $26,723,445